CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
ItalianoPIGA, Antonio Giulio
Dettaglio
PIGA, Antonio Giulio
SCIENZE CLINICHE E BIOLOGICHE
Pubblicazioni
Risultati 1 - 20 di 171 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | A 1-year randomized controlled trial of deferasirox versus deferoxamine for myocardial iron removal in beta-thalassemia major (CORDELIA). | 2014 | Pennell DJ;Porter JB;Piga A;Lai Y;El-Beshlawy A;Belhoul KM;Elalfy M;Yesilipek A;Kilinç Y;Lawniczek T;Habr D;Weisskopf M;Zhang Y;Aydinok Y |
| 2 | 13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study | 2015 | De Montalembert, Mariane; Abboud, Miguel R.; Fiquet, Anne; Inati, Adlette; Lebensburger, Jeffrey D.; Kaddah, Normeen; Mokhtar, Galila; Piga, Antonio; Halasa, Natasha; Inusa, Baba; Rees, David C.; Heath, Paul T.; Telfer, Paul; Driscoll, Catherine; Al Hajjar, Sami; Tozzi, Alberto; Jiang, Qin; Emini, Emilio A.; Gruber, William C.; Gurtman, Alejandra; Scott, Daniel A. |
| 3 | A child with hyperferritinemia: case report | 2011 | M. Serra; F. Longo; A. Roetto; A. Sandri; A. Piga |
| 4 | A multi-center safety trial of the oral iron chelator deferiprone. | 1998 | COHEN A; GALANELLO R; PIGA A; VULLO C; TRICTA F |
| 5 | A new fast-moving variant causing erythrocytosis and mild hemolysis: Hb Gàmbara [beta 82(EF6)Lys-->Glu] | 1997 | IVALDI G ;SCIMÈ-DEGANI V ;DAVID O ;BAFFICO M ;BALDI M ;LEONE D ;MAZZOCCO M ;LEONE L ;PIGA A ;FURIAN E ;RICCO G |
| 6 | A newly-characterized alpha-thalassaemia-1 deletion removes the entire alpha-like globin gene cluster in an Italian family. | 1991 | FORTINA P.; DIANZANI I.; SERRA A.; GOTTARDI E.; SAGLIO G.; FARINASSO L.; PIGA A.; GABUTTI V.; CAMASCHELLA C. |
| 7 | A phase 2 study of the safety, tolerability and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload | 2012 | E. J. Neufeld; R. Galanello; V. Viprakasit; Y. Aydinok; A. Piga; P. Harmatz; G. L. Forni; F. T. Shah; R. F. Grace; J. B. Porter; J. C. Wood; J. Peppe; A. Jones; H. Y. Rienhoff |
| 8 | A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia | 2006 | CAPPELLINI MD; COHEN A; PIGA A; BEJAOUI M; PERROTTA S; AGAOGLU L; AYDINOK Y; KATTAMIS A; KILINC Y; PORTER J; CAPRA M; GALANELLO R; FATTOUM S; DRELICHMAN G; MAGNANO C; VERISSIMO M; THANASSIOU-METAXA M; GIARDINA P; KOURAKLI-SYMEONIDIS A; JANKA-SCHAUB G; COATES T; VERMYLEN C; OLIVIERI N; THURET I; OPITZ H; RESSAYRE-DJAFFER C; MARKS P; ALBERTI D |
| 9 | A prospective randomized controlled trial on the safety and efficacy of alternating deferoxamine and deferiprone in the treatment of iron overload in patients with thalassemia | 2006 | GALANELLO R; KATTAMIS A; PIGA A; FISCHER R; LEONI G; LADIS V; VOI V; LUND U; TRICTA F |
| 10 | A valine deletion of ferroportin 1: a common mutation in hemochromastosis type 4 | 2002 | A. ROETTO; A.T. MERRYWEATHER-CLARKE; F. DARAIO; K. LIVESEY; J.J. POINTON; G. BARBABIETOLA; A. PIGA; P.H. MACKIE; K.J. ROBSON; C. CAMASCHELLA |
| 11 | Alpha-interferon treatment of chronic hepatitis C after bone marrow transplantation for homozygous beta-thalassemia. | 1997 | GIARDINI C ;GALIMBERTI M ;LUCARELLI G ;POLCHI P ;ANGELUCCI E ;BARONCIANI D ;ERER B ;GAZIEV D ;PIGA A ;DI GREGORIO F ;ROMEO MA ;MANGIAGLI A ;PETRELLI E ;MURETTO P |
| 12 | Amlodipine reduces cardiac iron overload in patients with thalassemia major: a pilot trial. | 2013 | Fernandes JL;Sampaio EF;Fertrin K;Coelho OR;Loggetto S;Piga A;Verissimo M;Saad ST |
| 13 | Amustaline-glutathione pathogen-reduced red blood cell concentrates for transfusion-dependent thalassaemia | 2019 | Aydinok Y.; Piga A.; Origa R.; Mufti N.; Erickson A.; North A.; Waldhaus K.; Ernst C.; Lin J.-S.; Huang N.; Benjamin R.J.; Corash L. |
| 14 | Anemie ” eds, McGraw-Hill, Milano 1998, p 95-133. | 1998 | Garofalo F; Sacchetti L; Piga A; Ramenghi U |
| 15 | Assessing the efficacy of EBM teaching in a clinical setting | 2005 | Gardois, Paolo; Grillo, Gaetano; Lingua, Carla; Jourdan, Annalisa; Piga, Antonio; Fronteddu, Silvia |
| 16 | Assessment and management of iron overload in β-thalassaemia major patients during the 21st century: a real-life experience from the Italian Webthal project. | 2013 | Piga A;Longo F;Musallam KM;Cappellini MD;Forni GL;Quarta G;Chiavilli F;Commendatore F;Mulas S;Caruso V;Galanello R |
| 17 | Atrial fibrillation in β-thalassemia Major Patients: Diagnosis, Management and Therapeutic Options | 2018 | Barbero U, Fornari F, Guarguagli S, Gaglioti CM, Longo F, Doronzo B, Anselmino M, Piga A. |
| 18 | Behaviour of myeloid precursors in homozygous beta thalassaemia. | 1980 | GABUTTI V; MINIERO R; PIGA A; INCARBONE E; SACCHETTI L; BALEGNO G |
| 19 | Blood pressure and heart rate in young thalassemia major patients. | 1998 | VEGLIO F ;MELCHIO R ;RABBIA F ;MOLINO P ;GENOVA GC ;MARTINI G ;SCHIAVONE D ;PIGA A ;CHIANDUSSI L |
| 20 | Bone density and metabolism in thalassaemia. | 1998 | LALA R; CHIABOTTO P; DI STEFANO M; ISAIA GC; GAROFALO F; PIGA A |
Copyright © 2022